Edition:
India

Viemed Healthcare Inc (VMD.TO)

VMD.TO on Toronto Stock Exchange

12.29CAD
1:30am IST
Change (% chg)

$0.32 (+2.67%)
Prev Close
$11.97
Open
$12.00
Day's High
$12.59
Day's Low
$11.91
Volume
591,014
Avg. Vol
300,352
52-wk High
$16.19
52-wk Low
$3.36

Latest Key Developments (Source: Significant Developments)

Viemed Healthcare Quarterly Revenue Of $23.8 Mln
Tuesday, 5 May 2020 

May 4 (Reuters) - Viemed Healthcare Inc ::QUARTERLY REVENUE ROSE 31 PERCENT TO $23.8 MILLION.SEES Q2 2020 REVENUE ABOUT $42 MILLION TO $44 MILLION.QTRLY EARNINGS PER SHARE $ 0.11.  Full Article

Viemed Healthcare Sees Q1 2020 Revenue About $23.7 Mln To $23.9 Mln
Tuesday, 7 Apr 2020 

April 6 (Reuters) - Viemed Healthcare Inc ::VIEMED HEALTHCARE RAISES FIRST QUARTER GUIDANCE AND PROVIDES UPDATE ON OPERATIONS AND RESPONSE TO COVID-19 VIRUS.SEES Q1 2020 REVENUE ABOUT $23.7 MILLION TO $23.9 MILLION.VIEMED HEALTHCARE - IN RESPONSE TO COVID-19 VIRUS, BEGAN MODIFYING ITS CLINICAL PROTOCOLS TO LIMIT UNNECESSARY PATIENT ENCOUNTERS.VIEMED HEALTHCARE - AT THIS TIME, MODIFYING CLINICAL PROTOCOLS DO NOT APPEAR TO BE NEGATIVELY IMPACTING CO'S PATIENT ATTRITION RATE.VIEMED HEALTHCARE - WORKING TO SOURCE EQUIPMENT FOR THIRD PARTIES TO BE USED IN ACUTE FACILITIES TO ASSIST COVID-19 PATIENTS.VIEMED HEALTHCARE - ACTIVELY FULFILLING EQUIPMENT ORDERS IN MORE SEVERELY COVID-19 IMPACTED AREAS OF LOUISIANA AND NEW YORK.  Full Article

Viemed Healthcare Says Q4 Revenue $21.4 Mln
Tuesday, 3 Mar 2020 

March 3 (Reuters) - Viemed Healthcare Inc ::VIEMED HEALTHCARE ANNOUNCES 2019 RECORD FINANCIAL RESULTS.Q4 REVENUE $21.4 MILLION.SEES Q1 2020 REVENUE ABOUT $21.8 MILLION TO $22.8 MILLION.VIEMED HEALTHCARE QTRLY NET REVENUES OF $21.4 MILLION, UP 30% OVER REVENUE LESS BAD DEBT EXPENSE REPORTED FOR COMPARABLE QUARTER ENDED DEC 31, 2018.  Full Article

Viemed Healthcare Announces Financial Results For Third Quarter 2019
Tuesday, 5 Nov 2019 

Nov 4 (Reuters) - Viemed Healthcare Inc ::VIEMED HEALTHCARE ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER 2019.SEES Q4 2019 REVENUE ABOUT $24.7 MILLION TO $25.2 MILLION.Q3 REVENUE $23.5 MILLION.  Full Article

Viemed Healthcare Announces First Quarter 2019 Financial Results
Tuesday, 7 May 2019 

May 6 (Reuters) - Viemed Healthcare Inc ::VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS.VIEMED HEALTHCARE -REVENUES FOR QUARTER ENDED MARCH 31, 2019 WERE APPROXIMATELY $20.4 MILLION, UP 45% AS COMPARED TO QUARTER ENDED MARCH 31, 2018.  Full Article

Viemed Healthcare Comments On Competitive Bidding Announcement
Tuesday, 12 Mar 2019 

March 12 (Reuters) - Viemed Healthcare Inc ::VIEMED HEALTHCARE COMMENTS ON COMPETITIVE BIDDING ANNOUNCEMENT.VIEMED HEALTHCARE INC - IT APPEARS AS THOUGH CURRENT SUSPENSION OF CBP PROGRAM WILL CONTINUE UNTIL 2021.VIEMED HEALTHCARE INC - 130 AREAS THAT WERE INCLUDED IN LATEST ROUNDS OF CBP ARE GOING TO BE AREAS INCLUDED DURING 2021.VIEMED HEALTHCARE - CURRENTLY SERVING CMS PATIENTS IN 39 OF THESE CBP AREAS, AND IT CURRENTLY EXPECTS THAT IT WILL CONTINUE TO EXPAND ITS PATIENT BASE.VIEMED HEALTHCARE INC - ESTIMATES THAT LESS THAN 25% OF ITS REVENUE IS CURRENTLY INSIDE OF CBP AREAS.VIEMED HEALTHCARE - AWARE OF RECENT ANNOUNCEMENT BY CMS THAT NON-INVASIVE VENTILATORS WILL BE INCLUDED IN NEXT ROUND OF CBP EXPECTED TO BEGIN IN 2021.  Full Article

Viemed Healthcare Expects 2018 Revenue To Be About $65.2 Mln-$65.3 Mln
Tuesday, 5 Feb 2019 

Feb 4 (Reuters) - Viemed Healthcare Inc ::VIEMED HEALTHCARE ANNOUNCES 2018 PRELIMINARY FINANCIAL RESULTS AND DATE AND TIME FOR CONFERENCE CALL.VIEMED HEALTHCARE INC - PRELIMINARY RESULTS SHOW ANNUAL REVENUE TO BE APPROXIMATELY US$65.2-$65.3 MILLION.VIEMED HEALTHCARE INC - PRELIMINARY RESULTS SHOW ANNUAL ADJUSTED EBITDA TO BE IN RANGE OF US$17.2-17.3 MILLION..  Full Article

Viemed Healthcare Q3 Revenue $17.2 Million
Monday, 5 Nov 2018 

Nov 5 (Reuters) - Viemed Healthcare Inc ::VIEMED HEALTHCARE ANNOUNCES RECORD FINANCIAL RESULTS FOR THIRD QUARTER 2018.EXPECTS TO GENERATE TOTAL REVENUES OF APPROXIMATELY $17.9 - $18.4 MILLION DURING Q4 OF 2018.Q3 REVENUE $17.2 MILLION.  Full Article